Comprehensive genomic profiling of cell-free circulating tumor dna detects response to ribociclib plus letrozole in a patient with metastatic breast cancer

HIGHLIGHTS

  • who: Catarina Silveira et al. from the Instituto Medicina Molecular Jou00e3o Lobo Antunes, Faculdade Medicina Universidade, York New York, NY, USA have published the Article: Comprehensive Genomic Profiling of Cell-Free Circulating Tumor DNA Detects Response to Ribociclib Plus Letrozole in a Patient with Metastatic Breast Cancer, in the Journal: Biomolecules 2022, 1818 of 19/Dec/2017
  • how: The results are consistent with previous reports indicating that CCND1 gene was no longer observed .
  • future: Although these trials showed a consistent overall survival benefit future studies are needed to stratify drug response according to . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?